ConductScience.org, home

Paper8551603

Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.

Dalal S and 3 others. J Virol, 1996. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. Papers, record 8551603. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8551603

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.
PubMed
Journal
J Virol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2020-07-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dalal SS
2Gao QQ
3Androphy EJE J
4Band VV

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, ViralMajor topic
Oncogene Proteins, ViralMajor topic
PapillomaviridaeMajor topic
Repressor ProteinsMajor topic
Tumor Suppressor Protein p53Major topic
Base Sequence
Breast
Cell Line
DNA Primers
Epithelial Cells
Female
Humans
Molecular Sequence Data
Mutagenesis
Protein Binding
Temperature

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA 44174NCI NIH HHSUnited StatesR01CA044174PubMed and NIHNIH RePORTER
R01 CA64823NCI NIH HHSUnited StatesR01CA064823PubMed and NIHNIH RePORTER
R29 CA56803NCI NIH HHSUnited StatesR29CA056803PubMed and NIHNIH RePORTER

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17923592Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression.Carcinogenesis1994https://conductscience.org/library/papers/7923592PubMed
28090726Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8090726PubMed
37537374Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7537374PubMed
47624774Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.Science1995https://conductscience.org/library/papers/7624774PubMed
53036495Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.EMBO J1987https://conductscience.org/library/papers/3036495PubMed
62536832Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells.J Virol1989https://conductscience.org/library/papers/2536832PubMed
72919173Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2919173PubMed
82476573The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.J Virol1989https://conductscience.org/library/papers/2476573PubMed
92555178HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.EMBO J1989https://conductscience.org/library/papers/2555178PubMed
102556677The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes.Oncogene1989https://conductscience.org/library/papers/2556677PubMed
112153303Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2153303PubMed
122157286Association of human papillomavirus types 16 and 18 E6 proteins with p53.Science1990https://conductscience.org/library/papers/2157286PubMed
132631796Improved retroviral vectors for gene transfer and expression.Biotechniques1989https://conductscience.org/library/papers/2631796PubMed
142228312Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.Int J Cancer1990https://conductscience.org/library/papers/2228312PubMed
151978757Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.Science1990https://conductscience.org/library/papers/1978757PubMed
162259385Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.Nature1990https://conductscience.org/library/papers/2259385PubMed
172175676The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.Cell1990https://conductscience.org/library/papers/2175676PubMed
181845889In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential.J Virol1991https://conductscience.org/library/papers/1845889PubMed
191845902The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells.J Virol1991https://conductscience.org/library/papers/1845902PubMed
201651408The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.J Virol1991https://conductscience.org/library/papers/1651408PubMed

See all 36 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
34217322Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.Virol J2021https://conductscience.org/library/papers/34217322PubMed
33468698Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.mBio2021https://conductscience.org/library/papers/33468698PubMed
31426742In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants.BMC Mol Cell Biol2019https://conductscience.org/library/papers/31426742PubMed
30971468Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.J Virol2019https://conductscience.org/library/papers/30971468PubMed
29998190Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.Mol Ther Oncolytics2018https://conductscience.org/library/papers/29998190PubMed
29342959Structural Insights in Multifunctional Papillomavirus Oncoproteins.Viruses2018https://conductscience.org/library/papers/29342959PubMed
28886384HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.Cell2017https://conductscience.org/library/papers/28886384PubMed
28515303Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.J Virol2017https://conductscience.org/library/papers/28515303PubMed
28166181DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection.J Immunother2017https://conductscience.org/library/papers/28166181PubMed
26783529Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description.Biomed Res Int2015https://conductscience.org/library/papers/26783529PubMed
25789055Immunization with mutant HPV16 E7 protein inhibits the growth of TC-1 cells in tumor-bearing mice.Oncol Lett2015https://conductscience.org/library/papers/25789055PubMed
25031356High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells.J Virol2014https://conductscience.org/library/papers/25031356PubMed
24594273Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.Cell Biosci2014https://conductscience.org/library/papers/24594273PubMed
24376816Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.PLoS One2013https://conductscience.org/library/papers/24376816PubMed
23711382Papillomavirus E6 oncoproteins.Virology2013https://conductscience.org/library/papers/23711382PubMed
22284986Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.Virology2012https://conductscience.org/library/papers/22284986PubMed
21672263Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18.Virol J2011https://conductscience.org/library/papers/21672263PubMed
20702634MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6.J Virol2010https://conductscience.org/library/papers/20702634PubMed
20383192The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer.Oncogene2010https://conductscience.org/library/papers/20383192PubMed
19722895Therapeutic HPV DNA vaccines.Expert Rev Vaccines2009https://conductscience.org/library/papers/19722895PubMed

See all 42 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8551603

GET https://conductscience.org/api/papers/v1/8551603/references?page=2